{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T01:13:29Z","timestamp":1783559609286,"version":"3.55.0"},"publisher-location":"Cham","reference-count":61,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030345204","type":"print"},{"value":"9783030345211","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-34521-1_33","type":"book-chapter","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T08:05:40Z","timestamp":1586419540000},"page":"771-784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Heparanase in the Coagulation System"],"prefix":"10.1007","author":[{"given":"Yona","family":"Nadir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,10]]},"reference":[{"issue":"1","key":"33_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0049-3848(95)00209-X","volume":"81","author":"E Camerer","year":"1996","unstructured":"Camerer, E., Kolsto, A. B., & Prydz, H. (1996). Cell biology of tissue factor, the principal initiator of blood coagulation. Thrombosis Research, 81(1), 1\u201341.","journal-title":"Thrombosis Research"},{"issue":"16","key":"33_CR2","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1161\/01.CIR.101.16.2000","volume":"101","author":"D Corseaux","year":"2000","unstructured":"Corseaux, D., Meurice, T., Six, I., et al. (2000). Basic fibroblast growth factor increases tissue factor expression in circulating monocytes and in vascular wall. Circulation, 101(16), 2000\u20132006.","journal-title":"Circulation"},{"issue":"4","key":"33_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0049-3848(96)00139-9","volume":"83","author":"M Ernofsson","year":"1996","unstructured":"Ernofsson, M., & Siegbahn, A. (1996). Platelet-derived growth factor-BB and monocyte chemotactic protein-1 induce human peripheral blood monocytes to express tissue factor. Thrombosis Research, 83(4), 307\u2013320.","journal-title":"Thrombosis Research"},{"issue":"12","key":"33_CR4","doi-asserted-by":"crossref","first-page":"7078","DOI":"10.1016\/S0021-9258(19)39261-0","volume":"265","author":"M Clauss","year":"1990","unstructured":"Clauss, M., Murray, J. C., Vianna, M., et al. (1990). A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor\/cachectin. The Journal of Biological Chemistry, 265(12), 7078\u20137083.","journal-title":"The Journal of Biological Chemistry"},{"issue":"4","key":"33_CR5","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/j.1365-2141.1995.tb05420.x","volume":"91","author":"PW Collins","year":"1995","unstructured":"Collins, P. W., Noble, K. E., Reittie, J. R., et al. (1995). Induction of tissue factor expression in human monocyte\/endothelium cocultures. British Journal of Haematology, 91(4), 963\u2013970.","journal-title":"British Journal of Haematology"},{"issue":"5","key":"33_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1055\/s-2000-13203","volume":"26","author":"SF Yan","year":"2000","unstructured":"Yan, S. F., Pinsky, D. J., & Stern, D. M. (2000). A pathway leading to hypoxia-induced vascular fibrin deposition. Seminars in Thrombosis and Hemostasis, 26(5), 479\u2013483.","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"2","key":"33_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1128\/IAI.57.2.507-512.1989","volume":"57","author":"TA Drake","year":"1989","unstructured":"Drake, T. A., & Pang, M. (1989). Effects of interleukin-1, lipopolysaccharide, and streptococci on procoagulant activity of cultured human cardiac valve endothelial and stromal cells. Infection and Immunity, 57(2), 507\u2013512.","journal-title":"Infection and Immunity"},{"issue":"3","key":"33_CR8","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1172\/JCI117451","volume":"94","author":"Y Zhang","year":"1994","unstructured":"Zhang, Y., Deng, Y., Luther, T., et al. (1994). Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. The Journal of Clinical Investigation, 94(3), 1320\u20131327.","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"33_CR9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/ajh.10061","volume":"69","author":"T Nakasaki","year":"2002","unstructured":"Nakasaki, T., Wada, H., Shigemori, C., et al. (2002). Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. American Journal of Hematology, 69(4), 247\u2013254.","journal-title":"American Journal of Hematology"},{"issue":"2","key":"33_CR10","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nm0296-209","volume":"2","author":"J Contrino","year":"1996","unstructured":"Contrino, J., Hair, G., Kreutzer, D. L., & Rickles, F. R. (1996). In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease. Nature Medicine, 2(2), 209\u2013215.","journal-title":"Nature Medicine"},{"issue":"1","key":"33_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/(SICI)1097-0215(19980220)79:1<19::AID-IJC4>3.0.CO;2-Z","volume":"79","author":"R Koomagi","year":"1998","unstructured":"Koomagi, R., & Volm, M. (1998). Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: Correlation between tissue factor and angiogenesis. International Journal of Cancer, 79(1), 19\u201322.","journal-title":"International Journal of Cancer"},{"issue":"6595","key":"33_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/383073a0","volume":"383","author":"P Carmeliet","year":"1996","unstructured":"Carmeliet, P., Mackman, N., Moons, L., et al. (1996). Role of tissue factor in embryonic blood vessel development. Nature, 383(6595), 73\u201375.","journal-title":"Nature"},{"issue":"11","key":"33_CR13","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1111\/j.1538-7836.2006.02212.x","volume":"4","author":"Y Nadir","year":"2006","unstructured":"Nadir, Y., Brenner, B., Zetser, A., et al. (2006). Heparanase induces tissue factor expression in vascular endothelial and cancer cells. Journal of Thrombosis and Haemostasis, 4(11), 2443\u20132451.","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"3","key":"33_CR14","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/path.1871","volume":"208","author":"BA Lwaleed","year":"2006","unstructured":"Lwaleed, B. A., & Bass, P. S. (2006). Tissue factor pathway inhibitor: Structure, biology and involvement in disease. The Journal of Pathology, 208(3), 327\u2013339.","journal-title":"The Journal of Pathology"},{"issue":"4","key":"33_CR15","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/(SICI)1096-8652(199707)55:4<183::AID-AJH3>3.0.CO;2-O","volume":"55","author":"Y Kamikura","year":"1997","unstructured":"Kamikura, Y., Wada, H., Yamada, A., et al. (1997). Increased tissue factor pathway inhibitor in patients with acute myocardial infarction. American Journal of Hematology, 55(4), 183\u2013187.","journal-title":"American Journal of Hematology"},{"issue":"8","key":"33_CR16","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.2337\/diacare.25.8.1340","volume":"25","author":"PB Leurs","year":"2002","unstructured":"Leurs, P. B., Stolk, R. P., Hamulyak, K., et al. (2002). Tissue factor pathway inhibitor and other endothelium-dependent hemostatic factors in elderly individuals with normal or impaired glucose tolerance and type 2 diabetes. Diabetes Care, 25(8), 1340\u20131345.","journal-title":"Diabetes Care"},{"issue":"6","key":"33_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/00001721-199809000-00006","volume":"9","author":"M Yamamuro","year":"1998","unstructured":"Yamamuro, M., Wada, H., Kumeda, K., et al. (1998). Changes in plasma tissue factor pathway inhibitor levels during the clinical course of disseminated intravascular coagulation. Blood Coagulation & Fibrinolysis, 9(6), 491\u2013497.","journal-title":"Blood Coagulation & Fibrinolysis"},{"issue":"4","key":"33_CR18","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1046\/j.1365-2141.1998.00875.x","volume":"102","author":"N Iversen","year":"1998","unstructured":"Iversen, N., Lindahl, A. K., & Abildgaard, U. (1998). Elevated TFPI in malignant disease: Relation to cancer type and hypercoagulation. British Journal of Haematology, 102(4), 889\u2013895.","journal-title":"British Journal of Haematology"},{"issue":"1","key":"33_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0049-3848(01)00404-2","volume":"105","author":"N Iversen","year":"2002","unstructured":"Iversen, N., Lindahl, A. K., & Abildgaard, U. (2002). Elevated plasma levels of the factor Xa-TFPI complex in cancer patients. Thrombosis Research, 105(1), 33\u201336.","journal-title":"Thrombosis Research"},{"issue":"6","key":"33_CR20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00467-006-0061-2","volume":"21","author":"MM Al-Mugeiren","year":"2006","unstructured":"Al-Mugeiren, M. M., Abdel Gader, A. G., Al-Rasheed, S. A., & Al-Salloum, A. A. (2006). Tissue factor pathway inhibitor in childhood nephrotic syndrome. Pediatric Nephrology, 21(6), 771\u2013777.","journal-title":"Pediatric Nephrology"},{"issue":"1","key":"33_CR21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/s-0037-1608919","volume":"99","author":"Y Nadir","year":"2008","unstructured":"Nadir, Y., Brenner, B., Gingis-Velitski, S., et al. (2008). Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells. Thrombosis and Haemostasis, 99(1), 133\u2013141.","journal-title":"Thrombosis and Haemostasis"},{"issue":"11","key":"33_CR22","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3324\/haematol.2010.023713","volume":"95","author":"Y Nadir","year":"2010","unstructured":"Nadir, Y., Brenner, B., Fux, L., et al. (2010). Heparanase enhances the generation of activated factor X in the presence of tissue factor and activated factor VII. Haematologica, 95(11), 1927\u20131934.","journal-title":"Haematologica"},{"issue":"17","key":"33_CR23","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.jacc.2011.11.057","volume":"59","author":"AB Baker","year":"2012","unstructured":"Baker, A. B., Gibson, W. J., Kolachalama, V. B., et al. (2012). Heparanase regulates thrombosis in vascular injury and stent-induced flow disturbance. Journal of the American College of Cardiology, 59(17), 1551\u20131560.","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"33_CR24","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1073\/pnas.91.8.3353","volume":"91","author":"CA Sprecher","year":"1994","unstructured":"Sprecher, C. A., Kisiel, W., Mathewes, S., & Foster, D. C. (1994). Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 91(8), 3353\u20133357.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"3","key":"33_CR25","first-page":"M99","volume":"1471","author":"CR Parish","year":"2001","unstructured":"Parish, C. R., Freeman, C., & Hulett, M. D. (2001). Heparanase: A key enzyme involved in cell invasion. Biochimica et Biophysica Acta, 1471(3), M99\u2013M108.","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"33_CR26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1172\/JCI13662","volume":"108","author":"I Vlodavsky","year":"2001","unstructured":"Vlodavsky, I., & Friedmann, Y. (2001). Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. The Journal of Clinical Investigation, 108(3), 341\u2013347.","journal-title":"The Journal of Clinical Investigation"},{"issue":"2\u20133","key":"33_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/plac.2001.0774","volume":"23","author":"K Udagawa","year":"2002","unstructured":"Udagawa, K., Yasumitsu, H., Esaki, M., et al. (2002). Subcellular localization of PP5\/TFPI-2 in human placenta: A possible role of PP5\/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts. Placenta, 23(2\u20133), 145\u2013153.","journal-title":"Placenta"},{"issue":"7","key":"33_CR28","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1160\/TH16-10-0766","volume":"117","author":"M Tatour","year":"2017","unstructured":"Tatour, M., Shapira, M., Axelman, E., et al. (2017). Thrombin is a selective inducer of heparanase release from platelets and granulocytes via protease-activated receptor-1. Thrombosis and Haemostasis, 117(7), 1391\u20131401.","journal-title":"Thrombosis and Haemostasis"},{"issue":"26","key":"33_CR29","doi-asserted-by":"publisher","first-page":"39486","DOI":"10.18632\/oncotarget.8960","volume":"7","author":"H Cui","year":"2016","unstructured":"Cui, H., Tan, Y. X., Osterholm, C., et al. (2016). Heparanase expression upregulates platelet adhesion activity and thrombogenicity. Oncotarget, 7(26), 39486\u201339496.","journal-title":"Oncotarget"},{"issue":"5","key":"33_CR30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/glycob\/cwy011","volume":"28","author":"YX Tan","year":"2018","unstructured":"Tan, Y. X., Cui, H., Wan, L. M., et al. (2018). Overexpression of heparanase in mice promoted megakaryopoiesis. Glycobiology, 28(5), 269\u2013275.","journal-title":"Glycobiology"},{"issue":"1","key":"33_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1182\/blood.V95.1.19","volume":"95","author":"AC Ward","year":"2000","unstructured":"Ward, A. C., Touw, I., & Yoshimura, A. (2000). The Jak-stat pathway in normal and perturbed hematopoiesis. Blood, 95(1), 19\u201329.","journal-title":"Blood"},{"issue":"3","key":"33_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0092-8674(00)81167-8","volume":"93","author":"E Parganas","year":"1998","unstructured":"Parganas, E., Wang, D., Stravopodis, D., et al. (1998). Jak2 is essential for signaling through a variety of cytokine receptors. Cell, 93(3), 385\u2013395.","journal-title":"Cell"},{"issue":"18","key":"33_CR33","doi-asserted-by":"publisher","first-page":"8429","DOI":"10.1073\/pnas.90.18.8429","volume":"90","author":"O Silvennoinen","year":"1993","unstructured":"Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., et al. (1993). Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proceedings of the National Academy of Sciences of the United States of America, 90(18), 8429\u20138433.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"33_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1160\/TH15-04-0320","volume":"115","author":"I Kogan","year":"2016","unstructured":"Kogan, I., Chap, D., Hoffman, R., et al. (2016). JAK-2 V617F mutation increases heparanase procoagulant activity. Thrombosis and Haemostasis, 115(1), 73\u201380.","journal-title":"Thrombosis and Haemostasis"},{"issue":"3","key":"33_CR35","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1160\/TH13-12-1049","volume":"112","author":"E Axelman","year":"2014","unstructured":"Axelman, E., Henig, I., Crispel, Y., et al. (2014). Novel peptides that inhibit heparanase activation of the coagulation system. Thrombosis and Haemostasis, 112(3), 466\u2013477.","journal-title":"Thrombosis and Haemostasis"},{"issue":"7","key":"33_CR36","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/jth.13707","volume":"15","author":"Y Crispel","year":"2017","unstructured":"Crispel, Y., Ghanem, S., Attias, J., et al. (2017). Involvement of the heparanase procoagulant domain in bleeding and wound healing. Journal of Thrombosis and Haemostasis, 15(7), 1463\u20131472.","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"4","key":"33_CR37","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1016\/j.thromres.2011.03.008","volume":"128","author":"Y Nadir","year":"2011","unstructured":"Nadir, Y., Kenig, Y., Drugan, A., Shafat, I., & Brenner, B. (2011). An assay to evaluate heparanase procoagulant activity. Thrombosis Research, 128(4), e3\u2013e8.","journal-title":"Thrombosis Research"},{"issue":"4","key":"33_CR38","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bbrc.2006.01.048","volume":"341","author":"I Shafat","year":"2006","unstructured":"Shafat, I., Zcharia, E., Nisman, B., et al. (2006). An ELISA method for the detection and quantification of human heparanase. Biochemical and Biophysical Research Communications, 341(4), 958\u2013963.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"33_CR39","doi-asserted-by":"crossref","unstructured":"Matan, M., Axelman, E., Brenner, B., & Nadir, Y.Heparanase procoagulant activity is elevated in women using oral contraceptives. Human Reproduction, 28(9), 2372\u20132380.","DOI":"10.1093\/humrep\/det257"},{"issue":"1","key":"33_CR40","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.thromres.2011.09.021","volume":"130","author":"E Peled","year":"2012","unstructured":"Peled, E., Rovitsky, A., Axelman, E., et al. (2012). Increased heparanase level and procoagulant activity in orthopedic surgery patients receiving prophylactic dose of enoxaparin. Thrombosis Research, 130(1), 129\u2013134.","journal-title":"Thrombosis Research"},{"key":"33_CR41","unstructured":"Matan, M., King, D., Peled, E., et al. (2017). Heparanase level and procoagulant activity are reduced in severe sepsis. European Journal of Haematology."},{"issue":"7","key":"33_CR42","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s00277-015-2345-8","volume":"94","author":"Y Nadir","year":"2015","unstructured":"Nadir, Y., Saharov, G., Hoffman, R., et al. (2015). Heparanase procoagulant activity, factor Xa, and plasminogen activator inhibitor 1 are increased in shift work female nurses. Annals of Hematology, 94(7), 1213\u20131219.","journal-title":"Annals of Hematology"},{"key":"33_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.thromres.2016.01.014","volume":"139","author":"E Peled","year":"2016","unstructured":"Peled, E., Melamed, E., Portal, T. B., et al. (2016). Heparanase procoagulant activity as a predictor of wound necrosis following diabetic foot amputation. Thrombosis Research, 139, 148\u2013153.","journal-title":"Thrombosis Research"},{"issue":"2","key":"33_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1055\/s-2003-38833","volume":"29","author":"N Lanir","year":"2003","unstructured":"Lanir, N., Aharon, A., & Brenner, B. (2003). Procoagulant and anticoagulant mechanisms in human placenta. Seminars in Thrombosis and Hemostasis, 29(2), 175\u2013184.","journal-title":"Seminars in Thrombosis and Hemostasis"},{"issue":"6","key":"33_CR45","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/molehr\/8.6.566","volume":"8","author":"R Haimov-Kochman","year":"2002","unstructured":"Haimov-Kochman, R., Friedmann, Y., Prus, D., et al. (2002). Localization of heparanase in normal and pathological human placenta. Molecular Human Reproduction, 8(6), 566\u2013573.","journal-title":"Molecular Human Reproduction"},{"issue":"9","key":"33_CR46","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/molehr\/2.9.679","volume":"2","author":"R Goshen","year":"1996","unstructured":"Goshen, R., Hochberg, A. A., Korner, G., et al. (1996). Purification and characterization of placental heparanase and its expression by cultured cytotrophoblasts. Molecular Human Reproduction, 2(9), 679\u2013684.","journal-title":"Molecular Human Reproduction"},{"issue":"5","key":"33_CR47","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/j.thromres.2009.11.026","volume":"125","author":"Y Nadir","year":"2010","unstructured":"Nadir, Y., Henig, I., Naroditzky, I., et al. (2010). Involvement of Heparanase in early pregnancy losses. Thrombosis Research, 125(5), e251\u2013e257.","journal-title":"Thrombosis Research"},{"issue":"6","key":"33_CR48","doi-asserted-by":"publisher","first-page":"e444","DOI":"10.1016\/j.thromres.2010.09.007","volume":"126","author":"Y Nadir","year":"2010","unstructured":"Nadir, Y., Kenig, Y., Drugan, A., Zcharia, E., & Brenner, B. (2010). Involvement of heparanase in vaginal and cesarean section deliveries. Thrombosis Research, 126(6), e444\u2013e450.","journal-title":"Thrombosis Research"},{"key":"33_CR49","unstructured":"McCarthy C, Cotter FE, McElwaine S, et al. 2007 Altered gene expression patterns in intrauterine growth restriction: Potential role of hypoxia. American Journal of Obstetrics and Gynecology,196(1):70 e71\u201376."},{"issue":"12","key":"33_CR50","first-page":"3966","volume":"118","author":"KM Fetalvero","year":"2008","unstructured":"Fetalvero, K. M., Zhang, P., Shyu, M., et al. (2008). Prostacyclin primes pregnant human myometrium for an enhanced contractile response in parturition. The Journal of Clinical Investigation, 118(12), 3966\u20133979.","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"33_CR51","first-page":"467","volume":"59","author":"HT Salem","year":"1982","unstructured":"Salem, H. T., Westergaard, J. G., Hindersson, P., et al. (1982). Maternal serum levels of placental protein 5 in complications of late pregnancy. Obstetrics and Gynecology, 59(4), 467\u2013471.","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"33_CR52","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/cncr.20347","volume":"101","author":"SR Deitcher","year":"2004","unstructured":"Deitcher, S. R., & Gomes, M. P. (2004). The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma: A systematic review. Cancer, 101(3), 439\u2013449.","journal-title":"Cancer"},{"issue":"9195","key":"33_CR53","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/S0140-6736(99)06092-4","volume":"354","author":"J Rosing","year":"1999","unstructured":"Rosing, J., Middeldorp, S., Curvers, J., et al. (1999). Low-dose oral contraceptives and acquired resistance to activated protein C: A randomised cross-over study. Lancet, 354(9195), 2036\u20132040.","journal-title":"Lancet"},{"issue":"24","key":"33_CR54","first-page":"8821","volume":"63","author":"M Elkin","year":"2003","unstructured":"Elkin, M., Cohen, I., Zcharia, E., et al. (2003). Regulation of heparanase gene expression by estrogen in breast cancer. Cancer Research, 63(24), 8821\u20138826.","journal-title":"Cancer Research"},{"issue":"9","key":"33_CR55","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1093\/humrep\/det257","volume":"28","author":"M Matan","year":"2013","unstructured":"Matan, M., Axelman, E., Brenner, B., & Nadir, Y. (2013). Heparanase procoagulant activity is elevated in women using oral contraceptives. Human Reproduction, 28(9), 2372\u20132380.","journal-title":"Human Reproduction"},{"issue":"3","key":"33_CR56","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.thromres.2014.07.006","volume":"134","author":"Y Nadir","year":"2014","unstructured":"Nadir, Y., Sarig, G., Axelman, E., et al. (2014). Heparanase procoagulant activity is elevated and predicts survival in non-small cell lung cancer patients. Thrombosis Research, 134(3), 639\u2013642.","journal-title":"Thrombosis Research"},{"issue":"4","key":"33_CR57","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1160\/TH16-02-0119","volume":"116","author":"Y Crispel","year":"2016","unstructured":"Crispel, Y., Axelman, E., Tatour, M., et al. (2016). Peptides inhibiting heparanase procoagulant activity significantly reduce tumour growth and vascularisation in a mouse model. Thrombosis and Haemostasis, 116(4), 669\u2013678.","journal-title":"Thrombosis and Haemostasis"},{"issue":"1","key":"33_CR58","doi-asserted-by":"publisher","first-page":"e62","DOI":"10.1111\/aos.13170","volume":"95","author":"Y Hu","year":"2017","unstructured":"Hu, Y., Atik, A., Yu, H., et al. (2017). Serum heparanase concentration and heparanase activity in patients with retinal vein occlusion. Acta Ophthalmologica, 95(1), e62\u2013e66.","journal-title":"Acta Ophthalmologica"},{"key":"33_CR59","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.thromres.2018.09.061","volume":"171","author":"E Bayam","year":"2018","unstructured":"Bayam, E., Kalcik, M., Gurbuz, A. S., et al. (2018). The relationship between heparanase levels, thrombus burden and thromboembolism in patients receiving unfractionated heparin treatment for prosthetic valve thrombosis. Thrombosis Research, 171, 103\u2013110.","journal-title":"Thrombosis Research"},{"issue":"1","key":"33_CR60","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mad.2004.09.024","volume":"126","author":"J Campisi","year":"2005","unstructured":"Campisi, J. (2005). Aging, tumor suppression and cancer: High wire-act! Mechanisms of Ageing and Development, 126(1), 51\u201358.","journal-title":"Mechanisms of Ageing and Development"},{"issue":"11","key":"33_CR61","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1182\/bloodadvances.2017014050","volume":"2","author":"ML Bochenek","year":"2018","unstructured":"Bochenek, M. L., Bauer, T., Gogiraju, R., et al. (2018). The endothelial tumor suppressor p53 is essential for venous thrombus formation in aged mice. Blood Adv, 2(11), 1300\u20131314.","journal-title":"Blood Adv"}],"container-title":["Advances in Experimental Medicine and Biology","Heparanase"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-34521-1_33","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:41:49Z","timestamp":1615164109000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-34521-1_33"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030345204","9783030345211"],"references-count":61,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-34521-1_33","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"10 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}